Lloyd Advisory Services’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Lloyd Advisory Services's GILD Position: Q2 2026 in Review
Lloyd Advisory Services sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 2,381 shares — an estimated $332K sold.
Lloyd Advisory Services first reported a position in GILD in Q4 2019 and held it in 18 quarters. The position peaked at $598K in Q3 2023. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Lloyd Advisory Services reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
- Lloyd Advisory Services sold 2,381 Gilead Sciences shares in Q2 2026, an estimated $332K.
- Lloyd Advisory Services first reported a position in Gilead Sciences in Q4 2019 and held it in 18 quarters.
- Lloyd Advisory Services's Gilead Sciences position peaked at $598K in Q3 2023.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Lloyd Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.